Diabetes technology

Retrospective Validation of a Stage 5 Decision Support Algorithm Using Clinical Trial Data From Stage 4 Smart Insulin Pens

J Diabetes Sci TechnolPublished Retrospective analysis of randomised controlled trial data

Authors' conclusion

The frequency of algorithm-based coaching events served as a robust indicator of glycemic control.

Study context

Population
Individuals with diabetes managed with MDI in a 12-week RCT, with continuous glucose monitoring (CGM) and smart insulin pen data338 biweekly CGM profiles
Participants
58 individuals
Comparison
Coaching event frequency in CGM profiles not meeting vs meeting CGM targets

Primary result

As reported in the abstract

Coaching event frequency by CGM target achievement · each 14-day period
Hyperglycemia-related coaching frequency, profiles not meeting vs meeting TIR target
18.8 vs 34.8
Hyperglycemia-related coaching frequency, profiles not meeting vs meeting TAR >180 mg/dL target
18.3 vs 33.8
Missed bolus event frequency, TIR
7.6 vs 11.2
Missed bolus event frequency, TAR
7.0 vs 11.1
Higher frequencies in profiles not meeting hyperglycemia-related CGM targets
all P < .001
Discrimination of TIR and TAR target achievement by both coaching categories
all AUC > 0.7
Missed basal detection frequency associated with TIR and TAR target achievement
all P < .05
Hypoglycemia coaching discriminated absence of nocturnal time below range <54 mg/dL
AUC = 0.740
Basal insulin titration coaching frequency associated with nocturnal mean glucose changes
all P < .005
Real-time insulin and correction factor reduction recommendations independently associated with deterioration in TIR and TAR
all P < .05

Original publication

Retrospective Validation of a Stage 5 Decision Support Algorithm Using Clinical Trial Data From Stage 4 Smart Insulin Pens. J Diabetes Sci Technol. Published 3 August 2026. doi:10.1177/19322968261471490

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.